SCHEMBL23779761

SCHEMBL23779761

CCC(=O)NC1C(OC(C)=O)OC(COC(C)=O)C(OC(C)=O)C1OC(C)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.68
▸ KMT2A Q03164 1/20 0.56
▸ POLB P06746 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ CYP2D6 P10635 1/20 0.52
▸ THRB P10828 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ TGM2 P21980 1/20 0.49
▸ CYP3A4 P08684 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ NR3C1 P04150 1/20 0.48
▸ FYN P06241 1/20 0.48
▸ ADRA2A P08913 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ DRD4 P21917 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ CA2 P00918 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26979271 1.00 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23118203 1.00 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23777367 1.00 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL23118202 1.00 LMNA (0.68) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL13716536 0.90 LMNA (0.56) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL21138671 0.90 LMNA (0.65) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL21058368 0.90 LMNA (0.65) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL30032874 0.90 LMNA (0.65) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL25957762 0.90 LMNA (0.65) LMNAKMT2APOLBALDH1A1CYP2D6
SCHEMBL24294515 0.89 LMNA (0.56) LMNAKMT2APOLBALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3873486-A1 BIVALENT TARGETED CONJUGATES Arbutus Biopharma Corporation (CA) 2021-09-08 — — EP disclosed
Send feedback